Paxlovid Consultation

Frequently Asked Questions

1. What is Paxlovid?

Paxlovid® is an antiviral medicine used to treat COVID-19 in eligible people who are at increased risk of severe illness. It helps reduce the risk of hospitalisation and serious complications.

2. How soon do I need to start Paxlovid?

Paxlovid must be started within 5 days of COVID-19 symptoms beginning. The earlier treatment starts, the more effective it is likely to be.

3. Who is eligible for Paxlovid?

Eligibility depends on factors such as age, risk of severe COVID-19, underlying medical conditions, and current Pharmac funding criteria. A pharmacist will assess your individual circumstances.

4. Can a pharmacist provide Paxlovid?

Yes. Some trained pharmacists in New Zealand can assess eligibility and supply Paxlovid directly without requiring a separate prescription.

5. Why do I need a medication review?

Paxlovid can interact with a number of commonly prescribed medicines. A pharmacist will review your medications to ensure treatment is safe and appropriate.

6. What if I am not eligible for funded Paxlovid?

Paxlovid may be available through private purchase in some circumstances. Your pharmacist can discuss available options with you.

7. Can I get Paxlovid before I test positive?

No. Paxlovid is intended for people with confirmed or probable COVID-19 and must be started shortly after symptoms begin.

8. Do I need to visit the pharmacy in person?

Not always. Depending on your circumstances, consultation and medicine delivery options may be available to help reduce the spread of infection.